News - Aenitis

Past events

Aenitis will be participating in the Congrès France Bioproduction, March 19-20

Emmanuel Vincent, our CEO, will be attending the Congrès France Bioproduction, Tours, France, from 19 to 20 March. Aenitis, a pioneer in acoustic-based cell manipulation, is revolutionizing bioproduction with its non-invasive, scalable acoustofluidic technology. This innovation enables precise, sterile, and cost-effective cell processing for research, clinical, and industrial applications. Take the opportunity to meet Emmanuel and find out how we’re leading the way in bioproduction innovation!

Press releases

Bracco and Aenitis Join Forces to Develop “Acoustic Beads” for Advanced Rare and Complex Cell Sorting in Flow Processes

Access the full Press Release: English Version / French Version ● Pioneering industry collaboration: Bracco and Aenitis join forces to combine expertise in acoustophoresis and functionalised microsystems to revolutionise the sorting of rare and complex cells, driving innovation in biomanufacturing and advanced therapies● Transformative alternative for sorting rare and complex cells: Acoustic microspheres offer a new alternative to magnetic beads, enabling safer, more efficient and scalable solutions● This pioneering technology ensures biocompatibility, improved cell viability and cost-effective processing, making large-scale sorting of rare and complex cells faster and more accessible Paris, France, January 8, 2025 – Aenitis Technologies,

Past events

Aenitis will be participating in the JP Morgan 43rd Annual Healthcare Conference, January 13-16

Emmanuel Vincent, our CEO, will be attending the JP Morgan 43rd Annual Healthcare Conference in San Francisco, CA, USA, from 13 to 16 January. Aenitis, a pioneer in acoustic-based cell manipulation, is revolutionizing bioproduction with its non-invasive, scalable acoustofluidic technology. This innovation enables precise, sterile, and cost-effective cell processing for research, clinical, and industrial applications. Take the opportunity to meet Emmanuel and find out how we’re leading the way in bioproduction innovation!

Media coverage

Aenitis has been featured in Biotech et Finances

We are pleased to share that Aenitis has been featured in Biotech et Finances! Our CEO, Emmanuel Vincent, spoke with Guillaume Mollaret about our recent successful fundraising to redefine bioproduction with our unique acoustofluidic technology. During the discussion, Emmanuel Vincent also highlighted the addition of two new members to our Strategic Board and the significant benefits our technology brings to biomanufacturing, including increased yields, reduced costs and improved cell quality. Headline : « AENITIS: DE L’ACOUSTIQUE CELLULAIRE À L’HARMONIQUE DES FONDS » Read the full article on Biotech et Finances: https://biotech-finances.com/?s=aenitis

Media coverage

Aenitis has been featured in Les Echos

We are delighted to announce that Aenitis has been featured in Les Echos following our successful fundraising to redefine bioproduction with our sole-in-class acoustofluidic technology!Thanks to Paul Molga for this enriching interview. Headline: « Aenitis raises 6.5 million euros for its cell sorting machines by levitation »Read the full article on Les Echos: https://www.lesechos.fr/pme-regions/innovateurs/aenitis-attire-65-millions-deuros-pour-ses-machines-de-tri-cellulaire-par-levitation-2124332 Together, we set to redefine biomanufacturing and enhance effective cell processing for research, clinical, and industrial applications.

Press releases

Aenitis Secures Strategic Funding to Redefine Bioproduction with Sole-In-Class Acoustofluidic Technology (2024)

Access the full Press Release: English Version / French Version ● Aenitis is set to transform the bioproduction industry by addressing theincreasing need for scalable, cost-effective, and highly precise cell processingtechnologies.● Mitis™, the flagship product of its unique Acoustofluidic Technology, is alreadyused across various applications, from research to clinical and industrial scales,including cell sorting, isolation, concentration, and washing.● Funding round led by the European Innovation Council Fund, Quadrivium I fund(Seventure Partners) and Mifani Invest to support commercial launch and globalexpansion. Paris, France, October 10, 2024-– Aenitis Technologies, a pioneer in acoustic-based cellmanipulation, has successfully closed

News

Aenitis awarded

We are proud to announce that Aenitis Technologies has been awarded the 1st prize in the European EIT Health Catapult in the Medtech category. The jury was keen to reward the potential of our company and the quality of our Pitch!

News

Innovation contest

Paris, december 19th 2018 – Aenitis technologies, which develops new medical devices for cell manipulation and sorting based on the use of acoustic energy, was named laureate, in the health category, of the first wave of the innovation competition organized by bpifrance under the aegis of cgi, ademe and franceagrimer. This contest, which was first launched in december of 2017, aims to support innovative projects created by sme and start-up companies in order to foster the emergence of world-class french champions on major issues, especially in the field of health, new challenges for producing biological

News

2018 second semester

The second semester of 2018 was full of events for Aenitis Technologies. Let’s take these final few moments of the year to reminisce on the last six months: August: Acoustofluidic: Aenitis Technologies was a sponsor for the event that took place from August 29th to 31st in Lille. This annual gathering is dedicated to science, engineering and the use of acousto-fluidics from the micro to nanoscale. Our CEO, Emmanuel Vincent, gave a conference about the valorization of academic developments in acousto-fluidics through industrial swarming and startup companies. September : Access2Europe: The team of Aenitis Technologies

News

Seventure finalist

Aenitis Technologies was this week at the France Tech Transfer Invest (FTTI), thanks to the support of CNRS Innovation! Organized by Bpifrance, the SATT Network, CNRS, Inserm Transfert, INRIA and CEA – in partnership with the Tech Tour company – this two-days event brought together forty start-ups stemming from French research. We are very proud to have been able to participate and present our technology to nearly 70 French and international investors specialized in innovation.We are also pleased to have won the FTTI 2019 competition and to be one of three Medtech start-ups for the